Cardio Diagnostics Holdings, Inc. - CDIO

Sector: Healthcare · Industry: In Vitro & In Vivo Diagnostic Substances
Website: No information yet · Social: No information yet

Company profile

Powered by TradingView

Quarter snapshot

Latest / Compare
Q4 2025 · Q3 2025
Value (USD)
Total reported value ($000)
$347K
QoQ value delta ($000)
-$110K (-24.07%)
Implied price effect (QoQ)
-32.54%
Shares
Total shares
129,536
QoQ shares delta
+14,444 (+12.55%)
Total shares held by funds (by quarter)
Shares (left)

Fund holders include prior positions carried forward until a new 13F confirms a change. Reported holders have reported a position in this security for that quarter; this is not the total number of 13F filers.

Market chart (CDIO)

Powered by TradingView
Interactive chart by TradingView.

Top holders (Q4 2025)

Top 25 only Full list
Early Q2 2026 data: only 17 institutional holders reported so far. More will appear as funds file with the SEC.
Manager Value ($000) Shares % of 13F
DRW Securities, LLC 109 40,463 0.0%
BlackRock, Inc. 96 35,567 0.0%
VANGUARD GROUP INC 65 24,124 0.0%
GEODE CAPITAL MANAGEMENT, LLC 41 15,135 0.0%
CITADEL ADVISORS LLC 29 10,858 0.0%
PNC FINANCIAL SERVICES GROUP, INC. 3 1,350 0.0%
Tower Research Capital LLC (TRC) 2 777 0.0%
UBS Group AG 2 952 0.0%
BANK OF AMERICA CORP /DE/ 0 16 0.0%
CITIGROUP INC 0 26 0.0%
MORGAN STANLEY 0 100 0.0%
WOLVERINE ASSET MANAGEMENT LLC 0 104 0.0%
Arax Advisory Partners 0 6 0.0%
OSAIC HOLDINGS, INC. 0 16 0.0%
SHP Wealth Management 0 16 0.0%
SBI Securities Co., Ltd. 0 26 0.0%